This is a preview of subscription content, log in via an institution to check access.
Notes
Two authors were employees of Eli Lilly and Co.
Reference
Wielage RC, et al. Cost effectiveness of duloxetine for osteoarthritis: a Quebec societal perspective. Arthritis care and research 66: 702-8, No. 5, May 2014
Rights and permissions
About this article
Cite this article
Duloxetine cost effective in Canadian osteoarthritis patients. PharmacoEcon Outcomes News 704, 4 (2014). https://doi.org/10.1007/s40274-014-1283-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1283-3